New study unlocks clues to preventing low blood sugar in diabetes

NCT ID NCT06881472

First seen Oct 01, 2025 · Last updated May 12, 2026 · Updated 22 times

Summary

This study looked at how two natural substances—GIP (a gut hormone) and alanine (an amino acid from protein)—affect glucagon release in people with and without type 1 diabetes. Glucagon helps raise blood sugar when it drops too low, but people with type 1 diabetes often can't produce it properly. Ten participants were given GIP and alanine separately and together to measure their combined effect on glucagon. The goal is to better understand these interactions, which could lead to new ways to prevent dangerous low blood sugar in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Gentofte Hospital

    Hellerup, 2900, Denmark

Conditions

Explore the condition pages connected to this study.